Isocratic high-performance liquid chromatographic method with ultraviolet detection for simultaneous determination of levels of voriconazole and itraconazole and its hydroxy metabolite in human serum

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 8, 2005, Pages 3569-3571

  Khoschsorur, GholamAli ^a   Fruehwirth, Franz ^a   Zelzer, Sieglinde ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; HYDROXYITRACONAZOLE; HYDROXYVORICONAZOLE; ITRACONAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE;

ACCURACY; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID LIQUID EXTRACTION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ULTRAVIOLET SPECTROSCOPY;

ANTIFUNGAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; ITRACONAZOLE; PYRIMIDINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRIAZOLES; ULTRAVIOLET RAYS;

EID: 23044488792     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.8.3569-3571.2005     Document Type: Article

References (20)

1. Barchiesi, F., D. Arzeni, F. Caselli, and G. Scalise. 2000. Primary resistance to flucytosine among clinical isolates of Candida spp. J. Antimicrob. Chemother. 45:408-409.
2. Carrier, A., and J. Parent. 2000. Liquid chromatographic-mass spectrometric determination of itraconazole and its major metabolite, hydroxyitraconazole, in dog plasma. J. Chromatogr. B 745:413-420.
3. Crane, J. K., and H. T. Shih. 1993. Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine. Am. J. Med. 95:445-446.
4. Darouiche, R. O., A. Setoodeh, and E. J. Anaissie. 1995. Potential use of a simplified method for determination of itraconazole levels in plasma and esophageal tissue by using high-performance liquid chromatography. Antimicrob. Agents Chemother. 39:757-759.
5. Denning, D. W., P. Ribaud, N. Milpied, D. Caillot, R. Herbrecht, E. Thiel, A. Haas, M. Ruhnke, and H. Lode. 2002. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin. Infect. Dis. 34:563-571.
6. Denning, D. W., R. M. Tucker, L. H. Hanson, and D. A. Stevens. 1989. Treatment of invasive aspergillosis with itraconazole. Am. J. Med. 86:791-800.
7. Espinel-Ingroff, A. 2001. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J. Clin. Microbiol. 39:954-958.
8. Haria, M., H. M. Bryson, and K. L. Goa. 1996. Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections. Drugs 51:585-620.
9. Heykants, J., A. Van Peer, V. Van de Velde, P. Van Rooy, W. Meuldermans, K. Lavrijsen, R. Woestenborghs, J. Van Cutsem, and G. Cauwenbergh. 1989. The clinical pharmacokinetics of itraconazole: an overview. Mycoses 32(Suppl. 1):67-87.
10. Hosteller, J. S., J. Heykants, K. V. Clemons, R. Woestenborghs, L. H. Hanson, and D. A. Stevens. 1993. Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations. Antimicrob. Agents Chemother. 37:2224-2227.
11. Jeu, L., F. J. Piacenti, A. G. Lyakhovetskiy, and H. B. Fung. 2003. Voriconazole. Clin. Ther. 25:1321-1381.
12. Law, D., C. B. Moore, and D. W. Denning. 1994. Bioassay for serum itraconazole concentrations using hydroxyitraconazole standards. Antimicrob. Agents Chemother. 38:1561-1566.
13. Pennick, G. J., M. Clark, D. A. Sutton, and M. G. Rinaldi. 2003. Development and validation of a high-performance liquid chromatography assay for voriconazole. Antimicrob. Agents Chemother. 47:2348-2350.
14. Perea, S., G. J. Pennick, A. Modak, A. W. Fothergill, D. A. Sutton, D. J. Sheehan, and M. G. Rinaldi. 2000. Comparison of high-performance Chromatographic and microbiological methods for determination of voriconazole levels in plasma. Antimicrob. Agents Chemother. 44:1209-1213.
15. Perfect, J. R., D. V. Savani, and D. T. Durack. 1986. Comparison of itraconazol and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits. Antimicrob. Agents Chemother. 29:579-583.
16. Sharkey, P. K., M. G. Rinaldi, J. F. Dunn, T. C. Hardin, R. J. Fetchick, and J. R. Graybill. 1991. High-dose itraconazole in the treatment of severe mycoses. Antimicrob. Agents Chemother. 35:707-713.
17. Srivatsan, V., A. K. Dasgupta, P. Kale, R. R. Datla, D. Soni, M. Patel, R. Patel, and C. Mavadhiva. 2004. Simultaneous determination of itraconazole and hydroxyitraconazole in human plasma by high-performance liquid chromatography. J. Chromatogr. A 1031:307-313.
18. Wong, J. W., U. R. Nisar, and K. H. Yuen. 2003. Liquid Chromatographic method for the determination of plasma itraconazole and its hydroxy metabolite in pharmacokinetic/bioavailability studies. J. Chromatogr. B 798: 355-360.
19. Yao, M., L. Chen, and N. R. Srinivas. 2001. Quantitation of itraconazole in rat heparinized plasma by liquid chromatography-mass spectrometry. J. Chromatogr. B 752:9-16.
20. Zhou, L., R. D. Glickman, N. Chen, W. E. Sponsel, J. R. Graybill, and K. W. Lam. 2002. Determination of voriconazole in aqueous humor by liquid chromatography-electrospray ionization-mass spectrometry. J. Chromatogr. B 776:213-220.